Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
101 studies found for:    "Sclerosis" AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
"Sclerosis" AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)
Conditions: Urinary Incontinence;;   Multiple Sclerosis
Intervention: Behavioral: Paula method
2 Recruiting Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Conditions: Relapsing-remitting Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis;   Primary-progressive Multiple Sclerosis
Interventions: Drug: estriol;   Other: Placebo;   Drug: Norethindrone;   Other: Progestin Placebo
3 Recruiting A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Conditions: Menopause;   Multiple Sclerosis
Interventions: Drug: Tissue Selective Estrogen Complex;   Drug: Placebo
4 Unknown  Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Condition: Relapsing Remitting Multiple Sclerosis
5 Recruiting Teriflunomide Male Transmission Study
Condition: Multiple Sclerosis
6 Recruiting Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease
Conditions: Multiple Sclerosis;   Alzheimer's Disease
Intervention: Drug: [F-18]PBR06
7 Completed AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
Conditions: Multiple Sclerosis;   Clinically Isolated Syndrome
8 Recruiting Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis
Condition: Multiple Sclerosis
9 Recruiting Genes and Environment in Multiple Sclerosis
Condition: Multiple Sclerosis
10 Completed Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training
Conditions: Multiple Sclerosis;   Aquatic;   Exercise
Interventions: Behavioral: Exercise;   Behavioral: Control
11 Completed A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis
Condition: Progressive Multiple Sclerosis
Interventions: Drug: GZ402668;   Drug: placebo;   Drug: acyclovir
12 Completed Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Condition: Systemic Sclerosis
Intervention: Drug: Cialis
13 Recruiting EPID Multiple Sclerosis Pregnancy Study
Condition: Multiple Sclerosis
Interventions: Drug: Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG;   Drug: Extavia (interferon beta-1b), Novartis Pharma AG;   Drug: Rebif (interferon beta-1a), Merck Serono Europe Ltd;   Drug: Plegridy (peginterferon beta-1a), Biogen Idec Ltd;   Drug: Avonex (interferon beta-1a), Biogen Idec Ltd;   Drug: MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046);   Other: No MSDMDs therapy (control)
14 Completed Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: firategrast
15 Completed
Has Results
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: abatacept;   Drug: Placebo
16 Active, not recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
17 Completed Treatment of Multiple Sclerosis With Copaxone and Albuterol
Conditions: Autoimmune Diseases;   Multiple Sclerosis
Interventions: Drug: Glatiramer acetate;   Drug: Albuterol;   Drug: Albuterol placebo
18 Terminated Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
Conditions: Healthy Volunteers;   Multiple Sclerosis
Interventions: Drug: 2B3-201;   Drug: Placebo;   Drug: Methylprednisolone hemisuccinate
19 Unknown  POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: nomegestrol acetate;   Drug: estradiol;   Drug: placebo
20 Completed Safety of RG2077 in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: RG2077 (CTLA4-IgG4m)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years